Everything below concerns peptide synthesis. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-11-05. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory status differs sharply between jurisdictions. In Russia the peptide is registered as a prescription nasal preparation, while agencies such as the United States Food and Drug Administration have not approved it for any indication. Products sold elsewhere are typically labeled for laboratory research only, and such labels shift responsibility for safe handling to the purchaser. Because the same name covers pharmaceutical-grade nasal drops and bulk research powder, identity and purity documentation becomes the main practical concern when comparing sources.
Semax is a synthetic seven-amino-acid peptide whose sequence extends the ACTH(4-10) fragment with a C-terminal proline-glycine-proline tripeptide. The commonly cited sequence is Met-Glu-His-Phe-Pro-Gly-Pro, giving a molecular formula near C37H51N9O10S and a molecular weight close to 813.9 g/mol. It belongs to the broader class of synthetic ACTH fragments studied for central nervous system effects rather than for adrenal steroid stimulation. In practice the material appears as a lyophilized white powder for laboratory work or as a dilute saline solution in clinical settings.
Development is attributed to researchers at the Institute of Molecular Genetics in Moscow during the early 1980s, building on earlier Soviet work with ACTH fragments. Russian regulatory approval followed for intranasal use, and the compound has remained commercially available there for decades. Most published human data originate from Russian and, later, some Eastern European clinical reports, which are not always accessible in English translation. Outside that region the material is generally handled as a research chemical rather than a licensed medicine.
Later generations of the molecule include an N-acetylated form and an amidated form, both marketed online alongside the parent peptide. These variants differ in terminal chemistry and stability, and they are frequently discussed in the same breath even though they have not been compared in controlled trials. Supply outside formal healthcare systems comes largely from laboratories that synthesize peptides to order. Purity and identity of these materials vary widely, and no single body oversees the international trade.
Semax is a synthetic heptapeptide developed in the Soviet Union during the 1980s by researchers at the Institute of Molecular Genetics in Moscow. It was designed as a truncated analog of adrenocorticotropic hormone, retaining only the fragment spanning residues four through ten. Investigators sought a peptide that would preserve the cognitive effects associated with ACTH while eliminating the hormonal stimulation of the adrenal cortex. The compound entered clinical use in Russia during the following decade.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic heptapeptide (ACTH fragment analog) | Not a steroid; does not belong to the melanocortin agonist drugs by marketing category |
| Molecular formula | C37H51N9O10S (commonly cited) | Reported values vary slightly with salt and counter-ion content |
| Appearance | White to off-white lyophilized powder | A single batch may appear as a loose cake or fluffy solid |
| Solubility | Freely soluble in water and aqueous buffer | Stock solutions are usually prepared in sterile water or saline |
| Typical storage | −20 °C or below, desiccated and protected from light | Seal opened vials promptly to limit moisture uptake |
The compound was developed during the 1980s at the Institute of Molecular Genetics in Moscow as part of research on fragments of adrenocorticotropic hormone. Early work examined short ACTH-derived sequences that retained neurotrophic effects while lacking the endocrine activity of the full hormone. Semax entered clinical use in Russia during the 1990s, where it received registration for several neurological indications. Outside that region it remained primarily a laboratory research material rather than an approved therapeutic. English-language literature on it grew more slowly and frequently cited the original Russian studies.
Terminology around the compound varies by source. It appears in catalogues and papers as Semax, as the heptapeptide ACTH(4-7)-Pro-Gly-Pro, and under various alphanumeric laboratory codes used by individual suppliers. These names refer to the same sequence but may imply different salt forms, purity grades, or counter-ions. Peptide databases usually list the free base mass, while product descriptions sometimes report acetate or trifluoroacetate salts with a different formula weight. Because naming conventions for research peptides are not standardised across vendors, checking the declared sequence and measured mass is more reliable than relying on a trade name alone.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its design combines the ACTH(4-7) core fragment with a C-terminal Pro-Gly-Pro extension, a modification intended to improve stability and prolong activity. The molecule is hydrophilic, carries no lipid chains or glycosylation, and has a theoretical mass just over 810 daltons in its free form. All seven residues are proteinogenic amino acids, so no non-natural building blocks appear in the backbone. A free N-terminal methionine and C-terminal proline define the unmodified parent peptide.
Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.
The parent fragment ACTH(4-10) carries the sequence Met-Glu-His-Phe-Arg-Trp-Gly. Semax replaces the arginine and tryptophan positions with a proline-glycine-proline tail, giving Met-Glu-His-Phe-Pro-Gly-Pro. That change removes residues associated with adrenal stimulation, so the peptide does not drive cortisol release the way full ACTH does. This distinction shapes how the compound is grouped in the literature, where it sits with neuropeptides and peptide neuromodulators rather than with corticosteroids.
== History == Desomorphine was first discovered and patented in Germany by a German team working for Knoll in 1920. Desomorphine was later synthesised in the U.S. in 1932 and patented on 13 November 1934. In Russia, desomorphine was declared an illegal narcotic analgesic in 1998. However, while codeine-containing drugs generally have been prescription products in Europe, in Russia they were sold freely over the counter until June 2012. The number of users in Russia was estimated to have reached around one million at the peak of the drug's popularity.
=== Other effects of shortages === On 14 February, it was announced Festival del Habano, an annual cigar festival, was called off due to "the complex economic situation" caused by the "economic, commercial and financial blockade" by the U.S. On 17 February 2026, it was reported that many collection trucks had been left with empty fuel tanks, causing refuse to pile up on the streets of the capital, Havana, and other cities and towns. Only 44 of Havana's 106 rubbish trucks (approximately 41.5% of them) have been able to keep operating due to the fuel shortages, slowing rubbish collection, as waste piles up on Havana's street corners, the Reuters news agency reported on Monday, citing state-run news outlet Cubadebate. Canadian mining company Sherritt announced that it would pause operations at its mining facility in Moa. State media reported in June that the blockade was damaging the health sector, with locally produced medicines unavailable, kidney dialysis disrupted, and nutrition programs far under capacity. A United Nations human rights report estimated that agricultural output had fallen by 60% in June 2026 due to fuel shortages.
Arthritis – Types – Fibromyalgia by the CDC Fibromyalgia by the National Institute of Arthritis and Musculoskeletal and Skin Diseases Fibromyalgia by the American College of Rheumatology Fibromyalgia by the NHS
Transport theory provides an alternative interpretation of viscosity in terms of momentum transport: viscosity is the material property which characterizes momentum transport within a fluid, just as thermal conductivity characterizes heat transport, and (mass) diffusivity characterizes mass transport. This perspective is implicit in Newton's law of viscosity,
== Patterns of amino acid replacement == Evolution of proteins is slower than DNA since only nonsynonymous mutations in DNA can result in amino acid replacements. Most mutations are neutral to maintain protein function and structure. Therefore, the more similar amino acids are, the more probable that they will be replaced. Conservative replacements are more common than radical replacements, since they can result in less important phenotypic changes. On the other hand, beneficial mutations, enhancing protein functions are most likely to be radical replacements. Also, the physicochemical distances, which are based on amino acids properties, are negatively correlated with probability of amino acids substitutions. Smaller distance between amino acids indicates that they are more likely to undergo replacement.
Sources: en.wikipedia.org
=== Specific proposals === A variety of government task forces, expert panels, private institutions, politicians, and journalists have made recommendations for reducing the deficit and slowing the growth of debt. Several organizations have compared the future impact of these plans on the deficit, debt, and economy. One helpful way of measuring the impact of the plans is to compare them in terms of revenue and expense as a percentage of GDP over time, in total and by category. This helps illustrate how the different plan authors have prioritized particular elements of the budget.
=== Deprotecting carbamates === Some carbamate protecting groups such as carboxybenzyl (Cbz) or allyloxycarbonyl (alloc) can be deprotected using 2-mercaptoethanol in the presence of potassium phosphate in dimethylacetamide.
== The Monolith Summer School == Since 2004, BIA Separations has organized and hosted the Monolith Summer School and Symposium (MSS) which takes place every 2 years. MSS was established as there were no dedicated conferences to this technology and to bring together the top international scientists and researchers in the area of monolith chromatography to share their experiences and innovative applications.
Narrated by Heather Couper, produced by Stuart Carter, made by Pioneer Productions 5 December Serious Fun, about Sim City; the video game industry was 20bn, bigger than film industry; Peter Main of Nintendo; Japanese musician Dai Satō; Japanese games designer Shigeru Miyamoto, and how the 3-D effect on games was achieved through polygon rendering, such as the polygon mesh; games designer Ed Annunziata; Lucy Bradshaw (game developer) of Electronic Arts, of California, who developed SimCity in 1989; software engineer Craig Reynolds (computer graphics) of Electronic Arts; sports commentator John Madden, appearing in the EA Sports game Madden NFL; a wire-frame model of a face had around four thousand polygons; sequencing the voice with the movement of the face was done with a software package called KISS; the British Syndicate (1993 video game); Ron Martinez of Spectrum HoloByte, and their game Star Trek: The Next Generation – A World for All Seasons; Paul Rioux of Sega. Directed by Sheila Hayman, made by Tra La La 12 December End of a Dynasty, about the execution of the Romanov family on 17 July 1918 at Yekaterinburg in Sverdlovsk Oblast. Directed by Julian Nott, made by Peninsula Films
Sources: en.wikipedia.org
meaning one infectious person on average infects 0.4 susceptible people per day and recovers in 1/0.2=5 days. Thus when this person recovered, there are two people still infectious directly got from this person and
24 June – Dunedin Airport receives its first international flight—a Jetstar flight from Gold Coast Airport—since the start of the COVID-19 pandemic in 2020. 25 June – Nelson Hospital switches from coal to landfill gas as part of a nationwide decarbonisation shift. 26 June: A state of emergency is declared in the Wairau-Awatere Ward of Marlborough due to heavy rain. 32 Māori land trusts (representing over 150,000 landowners, hapu (sub-groups) and iwi (tribes) file legal proceedings against the New Zealand Crown at the High Court urging the Government to stop the degradation of fresh water, honour the Treaty of Waitangi and Māori rights over water and geothermal resources. The New Zealand Government passed legislation designating the Independent Children's Monitor as an independent Crown entity, dissolving the Children and Young People's Commission and reinstating the Children's Commissioner. 27 June: A state of emergency is declared in Nelson and Tasman due to heavy rain and flooding . Residents of parts of Spring Creek are asked to evacuate in response to concerns that heavy overnight rain could cause the Wairau River to flood. New Zealand First list Member of Parliament Tanya Unkovich resigns to concentrate on work in the private sector. 28 June – A tornado in Waitara damages 11 homes. 29 June — The Government's sentencing reforms, which reduces sentencing discounts and encourages cumulative sentencing, comes into effect. 30 June – Oji Fibre Solutions ceases paper production operations at its Kinleith Mill in Tokoroa, affecting 230 jobs.
Following the ("scientific", rather than "industrial") discoveries, insights, and experimental advances from Banting and Best's experiments with "diabetic dogs", the combined efforts of the Department's head, John Macleod (a former assistant to Robertson), its pharmacology lecturer, Banting, "a battlefield surgeon with minimal research experience", and former general practitioner from London, Ontario, assisted by both Macleod's undergraduate student, Best, and the biochemist, James Collip, Assistant Professor of Biochemistry at University of Alberta, at Toronto under a Rockefeller Travelling Fellowship (not added to the team until December 1921) — who not only had considerable research experience with "internal secretions, but also had considerable experience in making and administering tissue extracts" — culminated in the successful (23 January 1922) first-ever life-saving treatment of diabetes mellitus (now known as Type 1 diabetes) when the extract that Collip had isolated, extracted, and refined from cattle pancreases (i.e., refined by Collip to the extent that the team believed a human could tolerate) was injected into the almost moribund 13-year-old Leonard Thompson in the Toronto General Hospital. The pancreatic extract injected into Thompson's buttocks was "a murky, light-brown liquid containing much sediment, which dissolved to a considerable extent on being warmed" (WC.1, p.68). Thompson lived for another 13 years; he died, aged 27, of bronchopneumonia. In the view of the Tufts' Professor of Clinical Medicine, Joseph H.
Sources: en.wikipedia.org
It is a short synthetic peptide built from seven amino acids: methionine, glutamic acid, histidine, phenylalanine and three prolines. The sequence derives from the 4-10 fragment of adrenocorticotropic hormone with an added proline-glycine-proline tail. No plant or animal extract is involved; the material is produced by solid-phase peptide synthesis.
It was developed in the Soviet Union during the early 1980s by groups at the Institute of Molecular Genetics in Moscow. Russian approval for intranasal use followed, and it has been marketed there since. Western laboratories encountered it mainly through translated literature and, later, through online research-chemical trade.
It holds a Russian registration as a prescription nasal product but has no approval from the European Medicines Agency or the United States Food and Drug Administration. Buyers outside Russia usually receive material sold strictly for laboratory research. That distinction matters because research-grade and pharmaceutical-grade products carry different documentation and testing expectations.
It originated at the Institute of Molecular Genetics in Moscow during the 1980s. The work was carried out by a Russian research group that specialized in peptide neuropharmacology.